Self-Management of Chronic Depressive Symptoms in Pregnancy

Sponsor
Virginia Commonwealth University (Other)
Overall Status
Completed
CT.gov ID
NCT02953990
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
120
1
1
29.4
4.1

Study Details

Study Description

Brief Summary

This study will provide information about the feasibility, acceptability, and preliminary effects of a biobehavioral self-management approach for perinatal depressive symptoms. This line of research will contribute to the body of knowledge about adjunctive therapies for depressive symptoms in pregnancy, a serious problem which contributes to poor maternal-child outcomes. Ultimately, this will contribute to the development and implementation of theoretically driven depression prevention/ resiliency building interventions and measurement of appropriate biobehavioral outcomes to determine the effectiveness of interventions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MOMS Program
N/A

Detailed Description

The investigators longitudinal mixed-methods study will use a one-group repeated measures intervention design coupled with qualitative methods to provide a comprehensive view of the feasibility, acceptability, and preliminary effects of the MOMS intervention. Semi-structured interviews, recruitment and retention numbers, and participant logs will be used to evaluate feasibility and acceptability of the intervention (Specific Aim 1). Recently collected archival comparison group data from an existing study will be used to contribute to explorations of preliminary effects of the intervention by comparing longitudinal psychobehavioral data, birth weight data (Specific Aims 2 and 3).

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Self-Management of Chronic Depressive Symptoms in Pregnancy
Study Start Date :
Sep 1, 2016
Actual Primary Completion Date :
Feb 12, 2019
Actual Study Completion Date :
Feb 12, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: MOMS Program

The MOMS Program involves: (1) mindfulness of symptoms and goal-setting through a nurse-participant partnership, and (2) 12 weeks of weekly community-based group prenatal yoga classes (75 minutes each) and self-directed home activity. Participants will engage in 12 weeks of weekly community-based group prenatal yoga classes (75 minutes each) and self-directed home practice.

Behavioral: MOMS Program

Outcome Measures

Primary Outcome Measures

  1. # individuals who enrolled in study/ # individuals who expressed interest in the study [Through study completion]

    Recruitment data

  2. # of participants enrolled/ # of participants completing study [Through study completion (end of 6-week postpartum visit)]

    Retention data

  3. total # of minutes of yoga [End of 12 week intervention]

    Adherence to yoga aspect of intervention

  4. Semi-structured qualitative interviews [End of 6 week postpartum visit]

    Participant satisfaction data

  5. Edinburgh Postnatal Depression Scale (EPDS) [Change from Baseline visit to end of 12 week intervention visit and at 1 year follow-up]

    Pregnancy-specific Depressive Symptoms

Secondary Outcome Measures

  1. Patient Health Questionnaire-9 (PHQ9) [Change from Baseline visit to end of 12 week intervention visit and at 1 year follow-up]

    Depressive Symptoms

  2. State-Trait Anxiety Inventory-State (STAI-S) [Change from Baseline visit to end of 12 week intervention visit and at 1 year follow-up]

    State Anxiety

  3. Ruminations Response Scale (RRS-10) [Change from Baseline visit to end of 12 week intervention visit and at 1 year follow-up]

    Ruminations

  4. Karitane Parenting Confidence Scale (KPCS) [Change from Baseline visit to end of 12 week intervention visit and at 1 year follow-up]

    Parenting Self-Efficacy

  5. Maternal Fetal Attachment Scale (MFAS) [Change from Baseline visit to end of 12 week intervention visit and at 1 year follow-up]

    Maternal-Child Attachment

  6. Baby's Birth Weight [6-week postpartum visit]

    per mother's report at 6-week postpartum visit

  7. Perceived Stress Scale (PSS) [Change from Baseline visit to end of 12 week intervention visit and at 1 year follow-up]

    Stress

  8. Physical Activity Self-Efficacy Scale (PASES) [Change from Baseline visit to end of 12 week intervention visit and at 1 year follow-up]

    Physical Activity Self-Efficacy

  9. total # of minutes in physical activity (including yoga) [End of 12 week intervention]

    Adherence to physical activity aspect of intervention (including yoga)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ≥ age 18;

  • self-report of depressive symptoms prior to pregnancy;

  • current depressive symptoms at a moderate-to-severe level, as defined by a score ≥10 on the Patient Health Questionnaire-9;

  • able to read, write, and understand English;

  • self-identify as black/African American (AA) or White;

  • absence of suicidal ideations (measured as low risk on the M.I.N.I. Neuropsychiatric Interview tool);

  • absence of pregnancy complications/physical conditions making physical activity (PA) inadvisable;

  • has not engaged in a consistent mindfulness-based PA routine during the pregnancy (such as yoga or similar activities more than once per month).

Exclusion Criteria:
  • If individual does not meet the inclusion criteria listed above, they are ineligible for the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Virginia Commonwealth University School of Nursing Richmond Virginia United States 23298

Sponsors and Collaborators

  • Virginia Commonwealth University
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

  • Principal Investigator: Patricia A Kinser, PhD, Virginia Commonwealth University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT02953990
Other Study ID Numbers:
  • HM20006941
  • 1R15HD086835-01A1
First Posted:
Nov 3, 2016
Last Update Posted:
Feb 19, 2019
Last Verified:
Feb 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Virginia Commonwealth University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 19, 2019